scispace - formally typeset
D

Dorte Aalund Olsen

Researcher at University of Southern Denmark

Publications -  38
Citations -  675

Dorte Aalund Olsen is an academic researcher from University of Southern Denmark. The author has contributed to research in topics: Cancer & Epidermal growth factor receptor. The author has an hindex of 13, co-authored 34 publications receiving 475 citations.

Papers
More filters
Journal ArticleDOI

Rapid SARS-CoV-2 Detection Using Electrochemical Immunosensor.

TL;DR: In this article, a proof-of-concept label-free electrochemical immunoassay for the rapid detection of SARS-CoV-2 virus via the spike surface protein was presented.
Journal ArticleDOI

Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer.

TL;DR: In this paper, the authors compared microvessel density (MVD) with single nucleotide polymorphisms (SNPs) in the vascular endothelial growth factor receptor (VEGFR)-1 and VEGFR-2 genes and furthermore, with quantitative measurements of the receptors in colorectal cancer (CRC) tissue.
Journal ArticleDOI

Epidermal growth factor receptor analyses in colorectal cancer: a comparison of methods

TL;DR: The results show a poor correlation between EGFR status at DNA, RNA and protein level and the predictive value of a combination of methods needs further evaluation in the clinical setting.
Journal ArticleDOI

Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors

TL;DR: In this paper, the potential differential protein content and gene expression of the four EGF receptors in benign and malignant ovarian tumors were analyzed by quantitative ELISA for HER1-HER4 protein concentrations and by real-time PCR for HER 1-HER 4 gene expression.
Journal ArticleDOI

Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer

TL;DR: High levels of PlGF and VEGF-A in tumor tissue were associated with significant shorter recurrence-free survival (RFS) in both univariate and multivariate analysis and encourage further investigations as prognostic markers in breast cancer patients.